The following side effects have been reported in patients with Chronic Obstructive Pulmonary Disease (COPD):
Rare (may affect less than 1 in 100 people)
Rare (may affect less than 1 in 1,000 people)
-Delayed growth in children and adolescents.
-Bone mineral density reduction.
-Glaucoma.
-Weight gain.
-Rounded face (moon-shaped) (Cushing's syndrome).
Your doctor will regularly monitor any of these side effects and ensure that you are taking the lowest dose of Plusvent to control your asthma.
Frequency not known, but may also occur:
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use Plusvent after the expiration date that appears on the label and on the packaging after CAD.The expiration date is the last day of the month indicated.
Do not store at a temperature above30°C.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection pointat the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Plusvent
Appearance of the product and contents of the packaging
Plusvent Accuhaler contains an alveoli strip. The alveoli protect the inhalation powder from atmospheric effects.
Each dose is pre-dispensed.
The devices are found in packaging of:
Only some packaging sizes may be commercially marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder:
GlaxoSmithKline, S.A.
P.T.M. C/ Severo Ochoa, 2
28760 Tres Cantos (Madrid)
Tel:+34900 202 700
Manufacturer:
Glaxo Wellcome Production Zone Industrielle nº 2 23 Rue Lavoisier, La Madeleine 27000 – Evreux (France)
or
Aspen Bad Oldesloe Gmbh, Industriestrasse 32-36, 23843 - Bad Oldesloe (Germany)
This leaflet was revised in July 2020.
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.